Domino Data Lab vs SAS Viya AI Governance
Both compete in Enterprise Incumbents. Domino Data Lab positions itself as “Enterprise MLOps and governance platform for building and running AI in regulated industries”, while SAS Viya AI Governanceleads with “Model management, monitoring and governance across the analytics lifecycle on SAS Viya”. The table below compares what each publishes.
Where Domino Data Lab pulls ahead
Publishes support for EU AI Act, GDPR, SOC 2, HIPAA, which SAS Viya AI Governance does not. Large regulated enterprises (pharma, financial services, government) needing rigorous model governance, reproducibility, and audit trails across hybrid or on-prem infrastructure
Where SAS Viya AI Governance pulls ahead
Regulated, analytics-heavy organizations in banking, insurance and government that need rigorous model management, validation and monitoring within the SAS ecosystem.
| Positioning | Enterprise MLOps and governance platform for building and running AI in regulated industries | Model management, monitoring and governance across the analytics lifecycle on SAS Viya |
|---|---|---|
| Category | Enterprise Incumbents | Enterprise Incumbents |
| Frameworks | EU AI Act, GDPR, SOC 2, HIPAA | None published |
| Deployment | SaaS, Cloud, On-prem | SaaS, Cloud, On-prem |
| Built for | Data Science / ML, GRC, Compliance, Risk, Security | Data Science / ML, Risk, Compliance |
| Founded | 2013 | 1976 |
| Headquarters | San Francisco, California, USA | Cary, North Carolina, USA |
| Ownership | Private, independent, venture-backed as of mid-2026; not acquired. Backed by Sequoia Capital, Coatue, NVIDIA, Snowflake, and UBS; raised a Series F round in August 2025. | Independent (private) |
| Funding | Approximately $224M+ raised across multiple rounds (through Series F, August 2025); investors include Sequoia Capital, Coatue Management, NVIDIA, Snowflake, and UBS | Private (independently held) |
| Pricing | Enterprise subscription / commercial license (custom quote; no public self-serve pricing) | Custom / enterprise |
| Key capabilities |
|
|
| Integrations | NVIDIA, Snowflake, AWS, Git / GitHub, GitHub Copilot, Claude Code, OpenAI Codex, Common ML frameworks and IDEs | SAS Viya, Python, R, Open-source model formats, MLOps/CI-CD pipelines |
| Notable customers | Bristol Myers Squibb, Lockheed Martin | None published |
| Best for | Large regulated enterprises (pharma, financial services, government) needing rigorous model governance, reproducibility, and audit trails across hybrid or on-prem infrastructure | Regulated, analytics-heavy organizations in banking, insurance and government that need rigorous model management, validation and monitoring within the SAS ecosystem. |
| Limitations | Heavyweight, enterprise-priced platform with no public self-serve tier; governance strength is oriented toward classic ML/model-risk workflows and regulated industries, and it is a broad MLOps suite rather than a focused, lightweight LLM-observability tool, which can mean higher implementation overhead for smaller teams. | Governance strength is tied to the SAS platform and analytics stack, and the product emphasizes statistical model lifecycle management over the regulation-mapping and policy-workflow features of dedicated GRC suites. |
Which should you shortlist?
Choose Domino Data Lab if large regulated enterprises (pharma, financial services, government) needing rigorous model governance, reproducibility, and audit trails across hybrid or on-prem infrastructure
Choose SAS Viya AI Governance if regulated, analytics-heavy organizations in banking, insurance and government that need rigorous model management, validation and monitoring within the SAS ecosystem.
Neither is a substitute for a governance program. Whichever you pick, you still need people who can define the policies the tool enforces.
AI Governance Tool Selection Kit
A vendor-comparison worksheet plus EU AI Act, NIST AI RMF and ISO/IEC 42001 requirement checklists — so you can shortlist tools against the obligations that actually apply to you.
Free. No spam — unsubscribe anytime.